Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betaine for CHDH-related Male Infertility
NCT02122211Phase 1Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Apr 2014
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of betaine in male infertility, sponsored by University of North Carolina at Chapel Hill. Primary endpoints: Change in sperm motility from baseline at Day 75, Change in sperm count from baseline at Day 75 and 4 more. Started Apr 2014; status: completed.
02
Drugs
betaine
03
Conditions
male infertility
Beyond the preview
Go deeper on NCT02122211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02122211.